메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기

BUSINESS

Business

LuxBank
  • Strain Library

    Difficult-to-culture (Fastidious)

    Beneficial Strains

    Pathogenic Strains

  • Genomic Analysis

    Functional Gene Discovery

    Disease & Metabolic Pathway Prediction

    Mechanism of Action (MoA) Identification

    Functional Expansion

  • Disease Matching

    Microbiome DB & Genome-based Matching

Through 30 years of research, we possess 3,854 types of beneficial microbial strains
and a comprehensive genomic database.

Business Execution Strategy

Phase 04

Commercialization of First-in-class innovative drugs
(Licensing & Commercialization with Global Big Pharma)

Phase 03

Development of premium medifood through human clinical trials

Phase 02

Validation through preclinical research

Phase 01

Discovery of candidate functional materials
using the Pangenome Miner™ platform